BRIEF-Flex Pharma provides FLX-787 nocturnal leg cramp regulatory and clinical update
Oct 13 Flex Pharma Inc
* Provides FLX-787 nocturnal leg cramp regulatory and clinical update
* Efficacy signals seen in subanalyses of exploratory human studies of FLX-787
* Parallel design phase 2 trial planned for first half 2017 based upon FDA pre-IND responses
* Says company is planning a parallel design phase 2 study in nlc to be initiated in first half of 2017 Source text for Eikon: Further company coverage:
AT&T reaches deal to buy Time Warner for more than $80 billion -WSJ
Oct 22 AT&T Inc reached a deal to buy media company Time Warner Inc for more than $80 billion, The Wall Street Journal reported on Saturday.
Trump vows to weaken U.S. media 'power structure' if elected
GETTSYBURG, Pa. , Oct 22 U.S. Republican presidential candidate Donald Trump promised on Saturday to foil a proposed deal for AT&T Inc to buy Time Warner Inc if he wins the Nov. 8 election, arguing it was an example of a "power structure" rigged against both him and voters.